With a combined revenue of $21 trillion and $2.1 trillion in profits, the 2026 Fortune 500 is the definitive list of America's largest companies.

Fortune 500

Almost $20 trillion in revenue—and a record-breaking $1.87 trillion in profits. Introducing the 2025 Fortune 500, the definitive list of the biggest companies in America.

Industries included in the sector are electrical equipment and industrial machinery.

Fortune Sector Leaders: Industrials

The Fortune 500, in its 70th year in 2024, ranks the biggest U.S. companies by revenue.

The Fortune 500, in its 69th year in 2023, ranks the biggest U.S. companies by revenue.

This year’s Fortune 500 marks the 68th running of the list.

This year’s Fortune 500 marks the 67th running of the list.

In 2020, the industrial manufacturing conglomerate took in $6.6 billion in revenue, a 6% drop from the year prior, due to pandemic-related challenges to its business. But Dover outperformed its forecast during the first quarter of 2021, after demand rebounded for products including industrial pumps and food refrigeration equipment.

This year's Fortune 500 marks the 66th running of the list.

F500-2020-433-Dover

The manufacturing conglomerate makes equipment and components that can be found in pipelines for oil, gas and chemicals; in fuel pumps; and in food-service systems, among many other places.

This year's Fortune 500 marks the 65th running of the list.

Here are the World's Most Admired Companies for 2018 as ranked in their industries. See who made the list.

World's Most Admired Companies

This year's Fortune 500 marks the 64th running of the list.

This year's Fortune 500 marks the 63rd running of the list.

Here are the World's Most Admired Companies for 2016 as ranked in their industries. See who made the list.

This year's Fortune 500 marks the 62nd running of the list.

Business insiders have spoken: Asked which companies they most admire, more than 4,100 executives, directors, and analysts chose these top 50 All-Stars.

This year's Fortune 500 marks the 61st running of the list. Wal-Mart claims the top spot again. See who made the list.

Wal-Mart stayed on top as its sales crept closer to half-a-trillion dollars. Apple moved into the top five. And UnitedHealth Group continued its steady climb. 

Company Info

Industry

Location

Industry Rank

Website

Overall Score

Key Attributes Of Reputation

Innovation

People Management

Use of Corporate Assets

Social Responsibility

Quality of Management

Financial Soundness

Long-Term Investment Value

Quality of Products/Services

Global Competitiveness

Key Financials (last Fiscal Year)

Revenues ($M)

Profits ($M)

Assets ($M)

Total Stockholder Equity ($M)

Profit Ratios

Profit as % of Revenues

Profits as % of Assets

Profits as % of Stockholder Equity

Earnings Per Share (last Fiscal Year)

Earnings Per Share ($)

EPS % Change (from prior fiscal year)

EPS % Change (5 year annual rate)

EPS % Change (10 year annual rate)

Total Return

Total Return to Investors (last year)

Total Return to Investors (5 year, annualized)

Total Return to Investors (10 year, annualized)

Dover is a diversified global manufacturer delivering innovative equipment, components, consumables, software, and support services across a wide range of industries. Its segments serve critical markets including vehicle aftermarket, aerospace and defense, clean energy, retail fueling, and industrial processing. Dover’s offerings span everything from precision pumps and fluid-handling solutions to refrigeration systems, digital printing, and product-traceability technologies. With a strong focus on engineering excellence and digital innovation, Dover helps customers operate more efficiently and sustainably.

Q2 2026

Q1 2026

Q4 2025

Q2 2025

Q1 2025

Q4 2024

Dover (DOV): Company Profile, Stock Price, News, Rankings

legacy

Dover

dover

Morning and welcome to the Dover's Fourth Quarter 2025 Earnings Conference Call. Speaking today are Richard J. Tobin, President and Chief Executive Officer; Chris Woeneker, Senior Vice President and Chief Financial Officer; and Jack Dickens, Vice President, Investor Relations. After the speakers' remarks, there will be a question-and-answer period. If you'd like to ask a question during this time, press star, then the number one on your telephone keypad. If you'd like to withdraw yourself from cue, you may press star two. As a reminder, ladies and gentlemen, the conference is being recorded, and your participation implies consent to our recording of this call. If you do not agree with these terms, please disconnect at this time. Thank you. I'd like to now turn the call over to Mr. Jack Dickens. Please go ahead.

Thank you, Stephanie. Good morning, everyone, and thank you for joining our call. An audio version of this call will be available on our website through February 19th, and a replay link of the webcast will be archived for 90 days. Our comments today will include forward-looking statements based on current expectations. Actual results and events could differ from those statements due to a number of risks and uncertainties which are discussed in our SEC filings. We assume no obligation to update our forward-looking statements. With that, I will turn the call over to Rich.

Thanks, Jack. Let's start on slide three. Overall, we had a good close to 2025. Our fourth quarter results reflect broad-based top-line strength across the portfolio, with organic growth up to five in the quarter, the highest level of the year. Revenue performance in the quarter was driven by robust trends, and our secular growth exposed markets as well as improving conditions in retail fueling and refrigerated door cases and services. Our strong bookings rates, which were up 10% in the quarter and 6% for the full year, continue to support underlying momentum across the portfolio, providing confidence in the durability of the demand as we enter the new year. Book-to-bill was seasonally high for the fourth quarter at 1.02. Segment EBITDA margins improved 60 basis points in the quarter to 24.8% on volume leverage and ongoing productivity initiatives.

All-in adjusted EPS at $9.61 was up 14% in the quarter, beating our raised third-quarter guide and 16% for the full year, a very encouraging result. Our solid operational results are complemented by our capital allocation strategy. The acquisitions that we closed in 2025 are off to a very good start, performing above their underwriting cases. Our current acquisition pipeline is interesting and is dominated by proprietary opportunities. Additionally, we initiated a $500 million accelerated share repurchase in November, underscoring our disciplined approach to capital deployment with meaningful balance sheet flexibility, where we remain well-positioned to deploy capital behind opportunities to enhance long-term shareholder value. We are taking a constructive outlook for 2026. Demand trends are solid and broad-based across the portfolio and are supported by our order book, with no individual end market presenting a material headwind based on current visibility.

Our balance sheet optionality enables us to dynamically respond to market conditions and opportunistically play offense. We are guiding for adjusted EPS of $10.45-$10.65 a share in 2026, which represents double-digit growth at the midpoint, consistent with our long-term trajectory and commitment to driving sustainable value creation to our shareholders. Let's go to slide five. Engineered Products revenue was down in the quarter on lower volumes and vehicle services, partially offset by double-digit growth within aerospace and defense components and software. Despite the organic volume decline, absolute segment profit improved in the quarter, with margins up over 200 basis points on well-executed structural cost management, product mix, and productivity initiatives. Clean Energy & Fueling was up 4% organically in the quarter, led by strong shipments and new orders in clean energy components, as well as North American retail fueling software and equipment.

Margins were down slightly in the quarter due to lower vehicle wash solutions, but still up materially for the year as we track towards our goal of 25% margin for the segment. Imaging and ID was up 1% organically in the quarter on growth in our core marking and coding business and in serialization software. EBITDA margin performance remains very good in the segment at 28%, though foreign currency translation and a higher mix of printer shipments slightly weighed on the margin in the quarter. Pumps & Process Solutions was up 11% organically, with growth in single-use biopharma components, thermal connectors for liquid cooling of data centers, precision components, and digital controls for natural gas and power generation infrastructure. SIKORA, which we acquired at the end of the second quarter in 2025, continues to outperform its underwriting case.

Polymer processing posted its first quarterly organic growth since Q1 of 2024 due to timing of large deliveries out of our backlog. Pumps and Process Solutions segment margin continues to perform at best-in-class levels. Climate and Sustainability Technologies posted positive organic growth of 9% in the quarter on continued double-digit growth in CO2 refrigeration systems and significant volume improvements in refrigerated display cases and engineering services, which was expected based on the Q3 booking exit rate. Demand for brazed plate heat exchangers, particularly for liquid cooling applications and data centers, continues to show robust momentum, with record quarterly shipments in the U.S. in the fourth quarter. Margins were up 250 basis points in the segment on volume leverage, solid execution, positive mix benefits from secular growth exposed end markets. With a book-to-bill of 1.21 in the quarter, the outlook for Climate and Sustainability Technologies is very encouraging for 2026.

Thanks, Rich. Let's go to our cash flow statement on slide six. Free cash flow in the fourth quarter was $487 million, or 23% of revenue. The fourth quarter was our highest cash flow quarter of the year, in line with historical trends. We were encouraged by Dover's full-year free cash flow result in 2025, which came in at 14% of revenue, an increase of nearly $200 million over the prior year. This increase was driven by improved cash conversion on higher year-over-year earnings, which more than offset expected increases in capital spend on growth and productivity projects. Our guidance for 2026 free cash flow is 14%-16% of revenue, as we expect continued strong conversion of operating cash flow. With that, let me turn it back to Rich.

Okay, I'm on slide seven. Full-year bookings were up 6% in 2025 after growing 7% in 2024. Q4 consolidated bookings were up over 10% over the prior year, and a seasonally high book-to-bill above one continued the trend of bookings momentum we experienced in the last two years. All five segments posted bookings growth in the fourth quarter, signaling broad-based demand strength for 2026. On slide eight, we highlight the capital allocation results from 2025 with our priorities. Our highest priority for capital spending is organic investment, which has proven to drive the highest returns on investment. We stepped up capital spending by over $50 million in 2025 over the prior year, with a healthy balance between growth capacity expansions behind some of our highest priority platforms, as well as productivity and automation investments, including some rooftop consolidations.

In total, we expect about $40 million of carryover profit from the previously announced productivity actions in 2026. Our next priority is growth through acquisitions in 2025. We deployed $700 million across four strategic acquisitions in high-end growth markets, three of which are in our highest priority Pumps and Process Solutions segment. These acquisitions are off to a tremendous start as we work to extract synergies through our center-led capabilities and leverage our global scale channels and supply chains. Finally, in 2025, we announced over $500 million of share repurchases, including the accelerated share repurchase program enacted in November. With robust cash flow generated in 2025, our dry powder in 2026 remains almost identical to the starting position from the previous year, as we have self-funded our CapEx, M&A, and share repurchases in 2025.

We are in an advantageous position, and I would expect that we will be active in 2026. Let's go to slide 9. Engineered Products expected to improve in 2026. Our aerospace and defense components business continued to experience significant demand tied to electronic warfare and signal intelligence solutions. Vehicle aftermarket, which declined by double digits organically in 2025, has shown some signs of moderating demand, with constructive bookings translating in 2025 and early 2026. With the divestitures of the Destaco and Environmental Solutions Group in 2024 and the growth of other segments of the portfolio, our Engineered Products segment now accounts for less than 15% of our total portfolio. The outlook of Clean Energy & Fueling remains solid across most of the businesses.

North American retail fueling is in the early innings of what we believe to be a new CapEx cycle, and the outlook in fluid transport and clean energy components is strong, with particularly robust demand in cryogenic applications. We expect the headwinds from the vehicle wash equipment and software to improve the headwinds in 2025 to improve in 2026. Clean Energy and Fueling should be among the leaders in margin accretion in 2026 on volume leverage and integration benefits from clean energy acquisitions. Imaging and ID should continue its long-term steady growth trajectory given its significant recurring revenue base and solid underlying demand. We are encouraged by the recent uptick in printer shipments, building the global installed base for continued long-term recurring revenue attachment. We expect demand conditions to remain constructive in Pumps and Process Solutions in 2026.

The outlook for artificial intelligence and energy infrastructure is robust, including thermal connectors for liquid cooling of data centers, precision components for natural gas infrastructure, and in Sikora's inspection equipment for high-voltage wire and cables. Demand for single-use biopharma components remains solid, driven by production growth and blockbuster drugs and the ongoing shift to single-use manufacturing methods. As noted, we got a tough comp in the first quarter in biopharma due to heavy restocking in early 2025, but overall, the Q4 exit run rate for the business should hold true for 2026. Finally, Climate and Sustainability Technologies should sustain its fourth quarter exit rate into 2026. CO2 refrigeration systems are expected to continue at a double-digit growth clip. We expect the recovery in refrigerated display cases and engineering services to continue, with national retailers signaling the intent to resume maintenance and replacement upgrade spending following a period of tariff-related delays.

We are experiencing robust demand across all geographies for brazed plate heat exchangers, with noteworthy growth in North America tied to liquid cooling of data centers, where we were booked well beyond Q1. Finally, let's go to slide 10. Full-year guidance is on the left. We'd expect seasonality in 2026 to be similar to the last few years, with Q1 volume slowly ramping into peak product delivery periods in the second and third quarters, with the fourth quarter representing an early indication of next year's outlook. We are encouraged by the momentum in our top-line performance, which marks an improvement over several years of organic growth belonging to our long-term standard. Notably, even during that period of moderated top-line growth, our business model showed its strength as we successfully expanded profitability through disciplined cost management, strong margin conversion, and value-creating capital deployment. The setup for 2026 is constructive.

We anticipate solid volume leverage on incremental revenue, as well as carryover benefits from prior period restructuring efforts and accretion from M&A. We are committed to continuing our long-term double-digit EPS growth trajectory into 2026. Finally, I'd like to thank our global teams for efforts to deliver these last year's results, and we look forward to serving our customers, partners, and investors in the year ahead. With that, Jack, let's go to Q&A.

Thank you. If you'd like to ask a question, simply press star, then the number one on your telephone keypad. If you would like to withdraw yourself from queue, you may press star two. We ask that participants limit themselves to one question and one clarifying question. We'll take our first question from Steve Tusa with JPMorgan.

Hey, good morning. Or geez, good afternoon. I got—

Yeah. Had to eat lunch, delay lunch for you guys.

Yeah. We'll go early in the morning next time around, but.

No, it's nice you got to avoid the other calls. That's helpful. Price cost, what are we looking at this year? I know you guys buy a bit of steel, so how are you thinking about managing the raws?

Yeah. I mean, I think right now we should do what we've done every year, probably like 1-1.5% over. Now, clearly, we're looking into commodity costs moving up going into the year. We can talk about incremental margin and what that means. So whether we've got to go back to the well or not, we'll see based on the trajectory.

Okay. So as of now, how much price are you embedding in the guide?

Okay. And then just one more question for you. You were pretty positive over the course of the quarter in your commentary. Anything you've seen in the last month or so or two months that would change that positive view and tone on just the general economy and business?

No. I mean, look, we were looking for the best organic growth quarter for the year, and we got it. We got the margin accretion that we looked for, considering kind of a little bit of the mix differential that we had in Q4 versus the previous couple of quarters. And book-to-bill is over one. So to me, I think that we hit the three kind of data points that we were looking for going into 2026. Our backlogs are good. Production performance should be pretty good in Q1. I think we got to don't get a little excited about production performance delivery because I think we'll really ramp. The seasonality will be the same as usual. But overall, yeah, I mean, we like the setup.

Thank you. We'll take our next question from Julian Mitchell with Barclays.

Hi, good morning. Maybe just to start off with very strong margin performance. But when we're thinking about kind of mix for 2026, and I know there's a lot of different businesses, but I suppose you're guiding for the highest organic sales growth in these segments with the lowest EBITDA margin. So maybe help us understand in DCEF and DCST what sort of operating leverage you're aiming for this year. There's sort of outsized cost savings, tailwinds, for example, that mean they can have very strong operating leverage alongside the high volume growth.

Yeah. No, you're spot on. I mean, what we're looking for in DCEF is the leverage on the revenue growth, plus that is the segment that will be impacted the most from prior period restructuring, so the rooftop. That'll come progressively through the year. So I think that the margin enhancement that we'd expect to get there would be a little bit back-end loaded just because of the restructuring benefits. The other one is DCST. You saw the margin jump in Q4 of 250 basis points comparatively. We'll see if we can get more on the volume going from there. Back to the question we had previously, that's where we're a little bit commodity exposed, particularly in copper. So do we bounce up the top-line expectations a little there to cover that? We'll see as the year goes on.

Right now, we've bought forward enough that we've got an idea, pretty good idea what we'll get probably in the first half of the year. We'll see if we need to take any pricing action there to cover any headwinds we've got on input costs. But you're spot on in terms of the mix.

Thanks. That's helpful. And maybe you've mentioned sort of seasonality rich a couple of times as being sort of a normal year ahead. So should we expect, let's say, year-on-year EPS growth and sales growth each quarter to not be that different from the full year framework on slide 10 is most?

Yeah. No, Julian, and that's right. Right? And when we looked at consensus for the year, it was oddly high for Q1, despite the fact that I think for 12 months, or not 12, or for nine months, we've been saying over and over again, be careful about the biopharma mix in Q1. So look, the full year is the full year. We'll hit the full year, but the seasonality should be the same as it's been sitting in your models historically.

Thank you. We'll take our next question from Amit Mehrotra with UBS.

Thanks. Hey, Rich. Good to talk to you. So just quick question on growth outlook for this year, 4%. Obviously, that's a good number, certainly a better number than the last couple of years, but it's a bit lower than sort of where we exited at in the fourth quarter. So maybe you can talk about it. Is that just prudent conservatism? Talk a little bit about that. And then it looks like if I look at the margin expansion for this year, it seems like the entirety is explained by maybe that $40 million wraparound productivity benefit. Is that right? And maybe is that just the mix effect kind of offsetting some of the volume leverage?

Yeah. I mean, the answer is yes and yes. I mean, it's early in the year. I mean, if you remember, I remember sitting here last year talking about our guidance, and then we ran into tariff tumult. So there is an amount of prudence in terms of the top line and the incremental margin at the end of the day. We talked about input costs and a variety of other things. These are numbers based on what we see in the backlog that we can execute on, whether we can move them up or not. We'll see quarter by quarter, but bookings momentum has accelerated into the end of last year.

So if we get that same kind of acceleration and we get the visibility as we move through the quarter, then I would expect, I think, that we progressively moved up EPS last year based on our original guidance. We would expect to kind of look at doing the same thing.

Yeah. That's helpful. And just related to that, so I know there was like a $150 million drawdown in refrigeration last year. Obviously, orders perked up in the third quarter and I guess are continuing to move in that direction. Do you feel confident you're able to get all of that back from where we stand today?

We're sold out for Q1. That's what I can tell you. So we're booking, and that is relatively short-cycle business, and we're booking well into Q2. So far, so good.

Okay. Very good. Thank you very much. Appreciate it.

Thank you. Our next question will come from Jeffrey Sprague with Vertical Research Partners.

Hey, thanks. Good day, everyone. Hey, Rich, just back on the incrementals and everything. We've touched on this a little bit, but just cutting through all the different mix changes and the like, I just want to make sure there's not anything below the line I'm missing. It looks like you're sort of guiding an observed incremental as reported about 35%. Is that right, or is there something else in between kind of OP and the bottom line to be aware of?

There's nothing really on the bottom line, Jeff. So you're close on the number, or you're right on the number, more or less.

Hey, and then second hand, right? So I'll be careful, but there's been some chatter that you've made some noise about kind of transformative sort of deal, generational deal, something very large. Maybe just to kind of address your appetite for something really large, or are you more inclined to stick with bolt-ons? Anything you could add there? Well, it's better than the retirement one from last year, so I'll take the transformational deal angle. We're not going to talk about anything in the pipeline. It's not been our history here. I mean, we have a very keen eye about execution risk. I'm sure that we'll do some M&A this year. If we were to consider something transformational, it would have to be shareholder-friendly to Dover at the end of the day.

So it's not as if we look at the business and the business that we own and say that we've squeezed everything out of it, and then now we've got to go do something to move it on. I think we've got a good algorithm here with bolt-on deals and growing the top line that we're not required to do anything, I guess, is the best way I can describe it.

Yeah. Hey, and then maybe I'm sorry, a third one, Jack, don't get mad at me, but just back on revenues, you noted maybe there's some conservatism here, but just thinking about this order growth rate that's been ahead of revenues now for a significant period of time and the fact that things like SIKORA are coming into organic at a faster rate. Is there just anything that's more long-cycle in the orders or something that doesn't convert quickly to kind of explain that apparent-looking disconnect?

I mean, at the end of the day, I mean, 3-5 historically without getting over our skis here is a pretty good number. But you're right. If I look at the velocity of orders coming in, you could roll forward and see. Q1 is always kind of an interesting quarter for us because we have a lot of production performance, and then we ship a lot in Q2, Q3. I think part of it is let's get into Q1. Let's see if we're manufacturing backlog or we're replacing what we're taking in production performance with new order flow. And if that's the case, then we'll take a close look at the top line. And again, I don't want to repeat myself. We are cognizant about input costs moving up, and if we have to take pricing action, that will actually drive some top-line growth also.

Right. Okay. Great. I'll leave it there. Thanks, Rich.

Thank you. We'll take our next question from Joe O'Dea with Wells Fargo.

Hi. Thanks for taking my questions. Wanted to start on the retail fueling CapEx cycle side of things, and just if you could elaborate on what you're seeing there, some details across regions, how you think that plays out over the course of 2026 in terms of any accelerating demand there.

It's very much a North American phenomenon. We've actually drawn down our exposures in both emerging markets in EMEA. We haven't left, but we've taken, that's actually been a drag on our top line over the last three or four years that we've gone and done 80/20 on the customer side. And other than that, it's, look, since 2001-ish, EVs were taking over the world, so there was not a lot of CapEx spent in retail fueling. And that was reflected maybe not in the margin, which I think we've done a fantastic job of, but on the top line, well, that's kind of turned the corner here. And if you go look at someone like Costco and what margins of fueling are right now, I think it's woken up the market that spreads at the retail are as high as they've ever been.

That's going to drive returns on projects.

Just on the restructuring side, you've got the $40 million carryover from actions last year. I think in the past you've touched on there could be more to do there. So just how you're approaching that when you would make any decisions around it, parts of the business that would see a bigger impact if you do decide to do more?

I think we've got a pretty full plate on what we're doing now. So there's a lag time between looking at proposals and then enacting them. If you take refrigeration, we're actually going to carry extra fixed costs for the first half of the year as we're taking down one facility and building another one. So we don't really get the benefit of that until the back half of next year. And that's the same for clean energy to a certain extent. But yeah, look, every year we've got a goal of attacking fixed costs. So we'll update you as we take the charges. We'll tell you what they are and where they are.

Thank you. We'll take our next question from Nigel Coe with Wolfe Research.

Hey, thanks. Good afternoon, guys. So Rich, I thought it'd be interesting to think about growth bifurcated between the 20% of what you call sector growth markets, and that's been growing double digits. And then the trough markets that are, I don't know, 40%-50%, Maag, SWEP, Belvac, VSG, Refrigeration. Just maybe just talk about what you're seeing in those two buckets in 2026.

Yeah. The growth bucket is going really well. There's really nothing to add to it. So anything that we'd said over the previous three quarters of last year, that trajectory has continued. So we're good there. I mean, the ones that have been a headwind, I mean, in Belvac, that's when we were just going to have to wait for the CapEx cycle to turn in can making. At least the conversations are getting there, but we don't really see it in backlog yet. On Vehicle Service Group, that has very much been a European story. And that is why, despite having the headwind on the top line, you don't see a lot of margin dilution because that's just reflective of the difference between the regions where we make high margins and not, to a certain extent.

I don't see that improving yet, but we're almost in year three of Europe being down there. So one would expect that that could turn, hopefully, during the year as we go forward. And refrigeration was an anomaly. I mean, we discussed it at length at the end of Q3. It was deferment, but we showed you the backlog building in Q4 and then look at the revenue growth and the margin expansion that we got in Q4. And as I mentioned, one of the questions, we're sold out for Q1 and we're booking well into Q2 now. So it doesn't look like there's only so much we can make in a given year, right, from a capacity point of view because we've actually taken a lot of capacity out there.

But what we said about going into 2026 is reflected in our backlog and was reflected in the revenue growth in Q4.

Okay. So refrigeration is recovering nicely. Sounds like Maag is still some headwinds there. Everything else fairly steady. Is that a good way to summarize that?

Yeah. Yeah. Maag's going to Maag's will see it because and you'll see it in the backlog because the dollar value of Maag's orders are so high, you'll know when it's coming. And right now, it's fair to say that the European chemical market is not doing well.

Yeah. That's not a shortcut. So just a quick clarification on the incremental margins. Is there a structuring payback to sustain 35% type incremental margins given the mixed pressures you've highlighted, or could that be?

No. I think that when you do the math and you look at the incrementals, I think that there's more upside than downside there.

Thank you. We'll take our next question from Scott Davis with Melius Research.

Rich, if you take a step backwards, this portfolio has changed quite a bit since you've taken the helm here. But what do you think the new entitlement kind of through cycle growth rate is of this portfolio you have now? Is it kind of right? We're kind of in that sweet spot around 5%? Is it 4%-5%?

Yeah. I mean, it is somewhere between 3-6%, depending on GDP and everything else, but clearly can do 5%.

Okay. That's what I would have thought. And guys, it's kind of been a while since we've talked about closed case, that whole nonsense thing that kind of went up and went down. And you've got a big installed base, and it's got to be aging out. Is there any way to think about the age of that installed base and kind of what the and be able to just socialize maybe the pent-up demand, how long those things last before they need to be replaced, etc.?

Well, it's a little bit of a tale of two cities. There's the CO2 rooftop, which is a change in technology play where knock wood, we are the North American market leader, and we're a co-leader in Europe, and we're the North American market leader, and we're doing really well because for a variety of reasons. That, I mean, put into the kind of the growth platforms. When Jack gives you those numbers, that CO2 business is in there. On the retail refrigerated door case business, we've taken that business from somewhere around 7% or 8% margin up into the very high teens now. We're finishing the last CapEx. We've basically rebuilt the entire industrial footprint there.

What we end up is with a core refrigeration business, which is around $500 million-ish at very nice margins and extremely good cash flow because it doesn't hold any working capital. It's worth significantly more today than it was back in the day when it was a discussion element. We'll grow that business, but we'll grow it for profitability, and we'll grow the CO2 side as quickly as we can because we're in the early innings there, and we've got a leadership position.

Okay. Helpful. Good color. Thank you. I'll pass it on. Best of luck this year, guys.

Thank you. We'll take our next question from Mike Halloran with Baird.

Hey. Good morning. Well, afternoon, everyone. So first on the clean energy margins, I prepared remarks. You mentioned the mid-20% target. Maybe just some timeline on when you think you can get there, Rich?

We're going to have to walk it up. So knock wood, should get into the low 20s this year and then walk it up from there. Can we accelerate it? It's going to depend on a little bit of mix. And I really want to see, we're still kind of in a transitional period on the footprint side. So what we really get out once we're done and what the benefit of the fixed cost absorption is once we get that done. So we're still doing that now, and we'll probably be completed by the end of the year on that. So just on the top line, we think we can get into the low 20s. From there, it's going to be on the roll forward of the cost out. And your guess is as good as mine.

We're really excited about the longer-term opportunity on the cryogenic side, which is not a super large business for us, but becoming larger. If that growth rate and that opportunity continues to expand, then we're very excited about it.

That makes sense. Then you touched on it briefly there, but you've had comments about there's only so much capacity to drive the growth. At the same time, you're also doing some of these internal initiatives, managing capacity lower. How do you see that push-pull as you work through the year? Are there areas where you might be putting incremental capital to expand capacity, or do we feel pretty good about the network as we sit here today? And then what's left on the pairing side?

Right now, CapEx is coming down in 2026 because of basically the completion of the expansion capacity and the restructuring capacity. So it's coming down. We feel good where we are. We are greenfielding a plant or beginning to greenfield a plant in North Carolina. That'll probably take us into 2027 by the time that's complete. So we've got a flexible model. I mean, we can kind of expand capacity relatively quickly. So besides the ones that we had in flight that we detailed in Q3, the only new one that I would add to that is the greenfield plant in North Carolina.

Thank you. We'll take our next question from Andrew Obin with Bank of America.

This is David Ridley-Lane on for Andrew Obin. I was wondering if you could talk about your exposure on sort of the natural gas power generation side. Do you supply components for just large turbines, or is it small turbines and reciprocating engines as well? And then notably, over the last kind of three, six months, there's been quite a number of capacity expansions by the equipment providers. Just over participate in that. Thank you.

The answer to your question is yes, yes, and yes. So everything from large turbines to midstream to reciprocating compressors, the large turbine business is kind of front-running the market right now. And while capacity in percentage terms has moved up quite a bit, these are very, very big units. So the unit value is high, but the number of units is not dramatic. We believe that there's going to be significant follow-on CapEx on the delivery side, meaning getting the natural gas to those turbines. We expect that to kick off, hopefully, but expect it to kick off in the back half of 2026.

Got it. And just to sort of clarify a thing from the slides, there's something about price cost in the fourth quarter for the Clean Energy and Fueling segment. Was that kind of one time, or?

Dover (DOV) Q4 2025 Earnings Call Transcript

Company Participants